INSIGHTS ON SOLID DOSE MANUFACTURING

• Overview Of Hot Melt Extrusion And Its Pharmaceutical Applications

  More than 40% of NCEs face aqueous solubility challenges. Here, we examine how hot melt extrusion addresses solubility, modified release, abuse deterrence, and scale-up across pharmaceutical development.

• Liquid Suspension Trends In The CDMO Space

  Liquid suspension formulations are rapidly growing in pharma, driven by patient needs, formulation advances, and CDMO innovation. 

• Inline Buffer Formulation Systems

  Eliminate large storage tanks and optimize cleanroom space with automated inline buffer formulation. See how on-demand fluid handling provides precise, real-time pH and conductivity control.

• How To Handle Intrinsic Product Powder Particles

  Powder filling creates intrinsic particles that interfere with continuous monitoring. Risk‑based strategies must separate product dust from true contamination to meet Annex 1 requirements.

• Cytiva's Aseptic Filling Workcell User Group

  1/9/2026

  Discover how global collaboration among aseptic filling experts is driving innovation and improving operations.

• De-Risking Production Of Complex Oral Solid Dosages: Considerations & Key Capabilities

  7/13/2026

  Reduce formulation and scale-up risk with integrated development and manufacturing expertise for complex OSD products.

• Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems

  4/20/2026

  Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.

• Zhunan Facility Site VR Tour

  12/23/2025

  Bora’s 36,000-square-meter Zhunan, Taiwan facility delivers flexible, high-quality cGMP oral solid dose manufacturing with access to major markets including North America and the EU.

• Navigating High-Potency OSD Manufacturing

  4/13/2026

  Learn how containment strategy, process design, and early risk‑based decisions influence operator protection, compliance, and long‑term manufacturing success as potency levels continue to rise.